Skip to main content

← All opportunities

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › NATIONAL INSTITUTES OF HEALTH › NATIONAL INSTITUTES OF HEALTH OLAO

RNA sequencing and whole genome sequencing services

Key facts

Response deadline
Nov 6, 2026
9:00 AM UTC-05:00
Set-aside
No set-aside
No Set aside used
Notice type
Presolicitation
Posted on SAM.gov
Oct 28, 2026
Archives Nov 7, 2026

Description

NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: 75N98027Q00020 The National Institutes of Health (NIH), National Cancer Ibstitute (NCI), intends to award a Firm-Fixed-Price Purchase Order to Plasmidsaurus Inc. for RNA sequencing and whole genome sequencing services for various wild-type, drug-treated cell lines and samples related to CRISPR research. Description of the Requirement The primary objective of this study is to investigate common lymphoma-related translocations involving MYC, BCL6, or BCL2, while also examining copy number alterations and making CNV calls for genes of interest. To achieve this, RNA sequencing will be provided for samples generated in the Staudt laboratory. RNA sequencing is essential for characterizing genome edits and conducting transcriptomic analysis. By utilizing Plasmidsaurus, a faster and more scalable alternative to traditional sequencing methods based on the latest Oxford Nanopore Technologies platform, we aim to generate results that will deepen our understanding of cellular mechanisms involved in B-cell lymphoma and guide future downstream experiments. RNA sequencing and Whole-genome sequencing are required to observe the effects of various drugs on gene expression, identify pathways, and discover novel pathways. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Show more
Plasmidsaurus uses the latest Oxford Nanopore Technologies platform, a faster, more scalable alternative to traditional sequencing. Using the latest Oxford Nanopore Technologies platform ensures accurate sequencing, which is crucial for reproducible experiments which will significantly advance our understanding of, and treatment for, B-cell lymphoma, which is vital to cancer research at the National Cancer Institute. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements. The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement. Capability statements must be submitted electronically to [email protected] no later than 9:00 a.m. EDT on November 6, 2026. Please reference Notice No. 75N98027Q00043 in the subject line of the submission.

From SAM.gov’s daily data file, as published on Nov 7, 2026 (UTC). SAM.gov’s latest daily file no longer lists this notice.

Contacts

Attachments

No attachment links are available here.

Record dates

Posted on SAM.gov: Oct 28, 2026
The agency’s publication date, as SAM.gov states it.
First recorded by BidLookup: Oct 29, 2026
The UTC day of the first read of SAM.gov’s listings that stored this notice.
Last confirmed: Nov 4, 2026
The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.
Description as published: Nov 7, 2026 (UTC)
The date of the daily data file this text came from.

Published by the agency on SAM.gov as notice 209a1a39e90d427b9849cc990f0f5bca. What these dates mean

Record

Solicitation number
75N98027Q00043
Search the index for this number
NAICS
32599 · All Other Chemical Product and Preparation Manufacturing
Product/service code
Q301 · REFERENCE LABORATORY TESTING
Place of performance
Bethesda, Maryland 20892
Contracting office
BETHESDA, MD 20892
SAM.gov notice ID
209a1a39e90d427b9849cc990f0f5bca